Full text
PDFPage 682
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Baldessarini R. J. Status of psychotropic drug blood level assays and other biochemical measurements in clinical practice. Am J Psychiatry. 1979 Sep;136(9):1177–1180. doi: 10.1176/ajp.136.9.1177. [DOI] [PubMed] [Google Scholar]
- Calil H. M., Avery D. H., Hollister L. E., Creese I., Snyder S. H. Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations. Psychiatry Res. 1979 Jul;1(1):39–44. doi: 10.1016/0165-1781(79)90026-x. [DOI] [PubMed] [Google Scholar]
- Lasagna L. Drug concentrations in neuropsychiatry. Introduction: the rational use of plasma drug levels in clinical medicine. Ciba Found Symp. 1979;(74):1–12. doi: 10.1002/9780470720578.ch1. [DOI] [PubMed] [Google Scholar]
- Smith R. C., Vroulis G., Shvartsburd A., Allen R., Lewis N., Schoolar J. C., Chojnacki M., Johnson R. RBC and plasma levels of haloperidol and clinical response in schizophrenia. Am J Psychiatry. 1982 Aug;139(8):1054–1056. doi: 10.1176/ajp.139.8.1054. [DOI] [PubMed] [Google Scholar]
- Yesavage J. A., Holman C. A., Cohn R., Lombrozo L. Correlation of initial thiothixene serum levels and clinical response. Comparison of fluorometric, gas chromatographic, and RBC assays. Arch Gen Psychiatry. 1983 Mar;40(3):301–304. doi: 10.1001/archpsyc.1983.01790030071009. [DOI] [PubMed] [Google Scholar]